Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pain Institute of Long Island is a Long Island-based interventional pain management practice focused on non-surgical and minimally invasive treatment of chronic and acute pain conditions. The practice became part of New York Health in December 2022 and was subsequently rebranded in 2023 as NY Spine & Pain Specialists while continuing to provide interventional spine and pain services. Its offerings include pain evaluations, injections, rehabilitation referrals, spinal cord stimulation, and minimally invasive procedures such as Mild, Vertiflex, and Intercept. The organization operates as a clinical healthcare services provider rather than a drug-development biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pain Institute of Long Island.